The respiratory syncytial virus (RSV) is making a comeback, and health experts are sounding the alarm. This winter, RSV has surpassed influenza as Australia's most common respiratory virus, prompting renewed calls for older Australians to get vaccinated. The situation is particularly dire for West Australians, with a significant rise in infections and a concerning lack of vaccine uptake.
The Immunisation Foundation of Australia's Mid-Winter RSV Report Card reveals a troubling trend. Over 83,000 cases have been recorded nationwide this year, with nearly 900 new infections reported daily since winter began. This marks the first time since national reporting began that RSV has taken the lead over influenza as Australia's leading respiratory virus. The situation is even more alarming in Western Australia, where 5044 RSV cases have been recorded, with a staggering 82% of them in the Perth metropolitan area.
The impact of RSV on older Australians is particularly devastating. Perth resident Diana Hamersley, 82, knows this all too well. She spent six weeks recovering from the virus last year, describing it as more debilitating than COVID-19. Hamersley's experience highlights the severe consequences of RSV, including constant coughing, fatigue, and a prolonged inability to perform daily activities.
The Australian Medical Association WA president, Dr Kyle Hoath, emphasizes the seriousness of the situation. He notes that RSV can lead to pneumonia in vulnerable individuals, causing severe illness and even death. Hoath warns that the virus poses a greater risk of complications than a common cold or influenza, and its impact on nursing homes and vulnerable communities will result in increased hospitalisations.
Despite the alarming rise in RSV cases, vaccine uptake remains a significant concern. Only 722,530 eligible older Australians have received the free RSV vaccine, leaving over one million people unprotected. This is in stark contrast to the flu vaccine, which has been administered to over 1.76 million eligible older Australians. The Immunisation Foundation's Catherine Hughes attributes this disparity to the recent availability of the RSV vaccine for free, only two months ago.
The high cost of the RSV vaccine before it became free was a significant barrier. Many older Australians had to choose between getting vaccinated and purchasing groceries. Ms. Hughes highlights the importance of making the vaccine accessible and affordable for older Australians, who are most vulnerable to the virus.
The situation is not limited to Western Australia. Across Australia, RSV is causing a surge in infections, with an average of 28,000 hospitalisations and 500 deaths annually. The aged care provider, Juniper, has reported success in containing RSV outbreaks in their residential homes through vaccination and infection prevention measures.
In conclusion, the resurgence of RSV poses a significant public health threat, particularly to older Australians. The alarming rise in cases and the low vaccine uptake demand urgent action. By making the RSV vaccine more accessible and raising awareness about its importance, we can protect vulnerable populations and reduce the devastating impact of this virus.
